Delivery Order SPE2DB22D2206-SPE2DB24FGR39
Award Date 4/15/24
Potential Completion Date 4/16/24
Potential Value $4.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for MONOVISC 88 MG/4 ML SYRINGE 4ML. The firm-fixed-price contract has a ceiling value of $9,125.06 and a period of performance through May 6, 2025. The award is not set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999.00. This IDC provides a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML. The order was placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 and runs through December 31, 2025. The current delivery order has a ceiling value of $11,677.99 and is a firm...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML. The contract is a firm fixed price delivery order with a ceiling value of $4,647.12 and a period of performance ending on May 31, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical, which...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a ceiling value of $4,932.42 and a completion date of May 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support...
- This is a federal delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, with a ceiling value of $18,756.29 and a period of performance through February 6, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, at a ceiling value of $4,905.57. The contract has an ultimate completion date of May 9, 2023 and is a firm fixed-price type. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML medical products. The order has a firm fixed price ceiling of $4,647.12 and a period of performance through September 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which enables the...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a Ceiling Value of $6,622.24. The contract is for a Firm Fixed Price and has an Ultimate Completion Date of March 31, 2025. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
- This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML. The contract has a ceiling value of $10,891.64 and is a firm fixed-price agreement. Amerisourcebergen, a major pharmaceutical distributor, is delivering these medical supplies to support military treatment programs and facilities through a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. The delivery order has a ceiling value of $10,889.48 and a completion date of April 10, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the contract does not have a set-aside designation. This delivery order is issued under a larger indefinite...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FGR39Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. The award has a ceiling value of $4,647.12 and a completion date of April 16, 2024. This order is placed under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC allows the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to support the U.S. Armed Forces and other government agencies. This particular order is not designated as a set-aside contract.
Generated 7/15/24, 6:40 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 4/15/24 |